Concepedia

Stephen E. McPherson

SE

4

Publications

544

Citations

4

H-Index

1983

Active since

Affiliations

Novartis (Switzerland)(Current)

Stephen E. McPherson is an author at Novartis (Switzerland) specializing in pharmacotherapy, natural sciences, and drug discovery.

Top concepts

Publications per year

1983–1988

4

Publications

4

CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

John Lehmann, Jennifer Schneider, Stephen E. McPherson et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 238 citations

CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.

John Lehmann, A. Hutchison, Stephen E. McPherson et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 226 citations

Antagonism of <i>N</i>-methyl-<scp>D</scp>-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists; evidence for possible allosteric coupling of NMDA and PCP receptors

Paul L. Wood, Douglas J. Steel, Stephen E. McPherson et al. · Canadian Journal of Physiology and Pharmacology · 1987 · 45 citations

Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models

Edmond C. Ku, Stephen E. McPherson, Carol Signor et al. · Biochemical and Biophysical Research Communications · 1983 · 35 citations

, , +10

Rows per page

1–4 of 4